RossR: The pathogenesis of atherosclerosis: A perspective for the 1990sNature1993, 362:801–809.
2.
SingCFMollPP: Genetics of atherosclerosisAnnu Rev Genet1990, 24:171–188.
3.
GoldsteinJLHobbsHHBrownMS: Familial hypercholesterolemia. In The Metabolic and Molecular Bases of Inherited Disease. 7th Edition. Edited by ScriverCRBeaudetALSlyWSValleD. New York: McGraw-Hill, Inc.; 1995, II:1981–2030.
4.
BoerwinkleEHixsonJE: Genes and normal lipid variationCurr Opin Lipidol1990, 1:151–159.
5.
DibCFauréSFizamesCSamsonDDrouotNVignalA: A comprehensive genetic map of the human genome based on 5,264 microsatellitesNature1996, 380:152–154.
6.
DaviesJLKawaguchiYBennettSTCopemanJBCordeilHJPritchardLE: A genome-wide search for human type I diabetes susceptibility genesNature1994, 371:130–136.
7.
HanisCLBoerwinkleEChakrabortyREllsworthDLConcannonPStirlingB: A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2Nature Genet1996, 13:161–166.
8.
CollinsFS: Positional cloning moves from perditional to traditionalNature Genet1995, 9:347–350.
9.
LiewCCHwangDMFungYWLaurenssenCCukermanETsuiS: A catalogue of genes in the cardiovascular system as identified by expressed sequence tagsProc Natl Acad Sci USA1994, 91:10645–10649.
10.
AdamsMDKerlavageARFleischmannRDFuldnerRABultCJLeeNH: Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequenceNature1995, 377 (suppl):3–174.
11.
BennettSTLucassenAMGoughSCLPowellEEUndlienDEPritchardLE: Susceptibility to human type I diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locusNature Genet1995, 9:284–292.
12.
KennedyGCGermanMSRutterWJ: The minisatellite in the diabetes susceptibility locus IDDM2 regulates insulin transcriptionNature Genet1995, 9:293–298.
13.
BonneyGELathropGMLalouelJ-M: Combined linkage and segregation analysis using regressive modelsAm J Hum Genet1988, 43:29–37.
14.
WeeksDELangeK: The affected-pedigree-member method of linkage analysisAm J Hum Genet1988, 42:315–326.
15.
AmosCI: Robust variance components approach for assessing genetic linkage in pedigreesAm J Hum Genet1994, 54:535–543.
16.
KruglyakLDalyMJReeve-DalyMPLanderES: Parametric and nonparametric linkage analysis: A unified multipoint approachAm J Hum Genet1996, 58:1347–1363.
17.
GreenbergDA: Linkage analysis of ‘necessary’ disease loci versus 'susceptibility' lociAm J Hum Genet1993, 52:135–143.
18.
SchaidDJSommerSS: Comparison of statistics for candidate-gene association studies using cases and parentsAm J Hum Genet1994, 55:402–409.
19.
SpielmanRSMcGinnisREEwensWJ: Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM)Am J Hum Genet1993, 52:506–516.
GriffinHGGriffinAM: DNA sequencing. Recent innovations and future trendsAppl Biochem Biotech1993, 38:147–159.
22.
GrompeM: The rapid detection of unknown mutations in nucleic acidsNature Genet1993, 5:111–117.
23.
OritaMIwahanaHKanazawaHHayashiKSekiyaT: Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphismsProc Natl Acad Sci USA1989, 86:2766–2770.
24.
AinsworthRISurhLCCoulterMMB: Diagnostic single strand conformational polymorphism, (SSCP): A simplified non-radioisotopic method as applied to a Tay-Sachs B1 variantNucl Acids Res1991, 19:405–406.
25.
JakschMGerbitzK-DKilgerC: Screening for mitochondrial DNA (mtDNA) point mutations using nonradioactive single strand conformation polymorphism (SSCP) analysisClin Biochem1995, 28:503–509.
26.
MyersRMLumelskyNLermanLSManiatisT: Detection of single base substitutions in total genomic DNANature1985, 313:495–498.
27.
MyersRMFischerSGManiatisTLermanLS: Modification of the melting properties of duplex DNA by attachment of a GC-rich DNA sequence as determined by denaturing gradient gel electrophoresisNucl Acids Res1985, 13:3111–3129.
28.
AbramsESMurdaughSELermanLS: Comprehensive detection of single base changes in human genomic DNA using denaturing gradient gel electrophoresis and a GC clampGenomics1990, 7:463–475.
29.
TakahashiNHiyamaKKodairaMSatohC: An improved method for the detection of genetic variations in DNA with denaturing gradient gel electrophoresisMutation Res1990, 234:61–70.
30.
MontandonAJGreenPMGianelliFBentleyDR: Direct detection of point mutations by mismatch analysis: Application to haemophilia BNucl Acids Res1989, 17:3347–3358.
31.
ZhengHHastyPBrennemanMAGrompeMGibbsRAWilsonJH: Fidelity of targeted recombination in human fibroblasts and murine embryonic stem cellsProc Natl Acad Sci USA1991, 88:8067–8071.
32.
DeebSSFailorRABrownBGBrunzellJDAlbersJJMotulskyAG: Association of apolipoprotein B gene variants with plasma apoB and low density lipoprotein (LDL) cholesterol levelsHum Genet1992, 88:463–470.
33.
PiedrahitaJAZhangSHHagamanJROliverPMMaedaN: Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cellsProc Natl Acad Sci USA1992, 89:4471–4475.
34.
ZhangSHReddickRLPiedrahitaJAMaedaN: Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein EScience1992, 258:468–471.
35.
SmithiesOMaedaN: Gene targeting approaches to complex genetic diseases: Atherosclerosis and essential hypertensionProc Natl Acad Sci USA1995, 92:5266–5272.
36.
SmithiesOKimH-S: Targeted gene duplication and disruption for analyzing quantitative genetic traits in miceProc Natl Acad Sci USA1994, 91:3612–3615.
37.
OwDWWoodKVDeLucaMde WetJRHelinskiDRHowellSH: Transient and stable expression of the firefly luciferase gene in plant cells and transgenic plantsScience1986, 234:856–859.
38.
de WetJRWoodKVDeLucaMHelinskiDRSubramaniS: Firefly luciferase gene: Structure and expression in mammalian cellsMol Cell Biol1987, 7:725–737.
39.
SayleRAMilner-WhiteEJ: RASMOL: Biomolecular graphics for allTrends Biochem Sci1995, 20:374–376.
40.
SobellJLHestonLLSommerSS: Delineation of genetic predisposition to multifactorial disease: A general approach on the threshold of feasibilityGenomics1992, 12:1–6.
41.
JulierCLucassenAVilledieuPDelepineMLevy-MarchalCDanzéPM: Multiple DNA variant association analysis: Application to the insulin gene region in type I diabetesAm J Hum Genet1994, 55:1247–1254.
42.
TempletonARBoerwinkleESingCF: A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping. I. Basic theory and an analysis of alcohol dehydrogenase activity InDrosophila. Genetics1987, 117:343–351.
43.
TempletonARSingCFKesslingAHumphriesS: A cladistic analysis of phenotype associations with haplotypes inferred from restriction endonuclease mapping. II. The analysis of natural populationsGenetics1988, 120:1145–1154.
44.
TempletonARCrandallKASingCF: A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping and DNA sequence data. III. Cladogram estimationGenetics1992, 132:619–633.
45.
TempletonARSingCF: A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping. IV. Nested analyses with cladogram uncertainty and recombinationGenetics1993, 134:659–669.
46.
HallmanDMVisvikisSSteinmetzJBoerwinkleE: The effect of variation in the apolipoprotein B gene on plasma lipid and apolipoprotein B levels. I. A likelihood-based approach to cladistic analysisAnn Hum Genet1994, 58:35–64.
47.
MahleyRW: Apolipoprotein E: Cholesterol transport protein with expanding role in cell biologyScience1988, 240:622–630.
48.
DavignonJGreggRESingCF: Apolipoprotein E polymorphism and atherosclerosisArteriosclerosis1988, 8:1–21.
49.
HallmanDMBoerwinkleESahaNSandholzerCMenzelHJCsázárA: The apolipoprotein E polymorphism: A comparison of allele frequencies and effects in nine populationsAm J Hum Genet1991, 49:338–349.
50.
StengårdJHZerbaKEPekkanenJEhnholmCNissinenASingCF: Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish menCirculation1995, 91:265–269.
51.
TikkanenMJHuttunenJKEhnholmCPietinenP: Apolipoprotein E4 homozygosity predisposes to serum cholesterol elevation during high fat dietArteriosclerosis1990, 10:285–288.
52.
BoerwinkleEBrownSPRohrbachKGottoAMJrPatschW: Role of apolipoprotein E and B gene variation in determining response of lipid, lipoprotein, and apolipoprotein levels to increased dietary cholesterolAm J Hum Genet1991, 49:1145–1154.
53.
GlatzJFCDemackerPNMTurnerPRKatanMB: Response of serum cholesterol to dietary cholesterol in relation to apolipoprotein E phenotypeNutr Metab Cardiovasc Dis1991, 1:13–17.
54.
MänttäriMKoskinenPEhnholmCHuttunenJKManninenV: Apolipoprotein E polymorphism influences the serum cholesterol response to dietary interventionMetabolism1991, 40:217–221.
55.
SavolainenMJRantalaMKervinenKJärviLSuvantoKRantalaT: Magnitude of dietary effects on plasma cholesterol concentration: Role of sex and apolipoprotein E phenotypeAtherosclerosis1991, 86:145–152.
56.
CobbMMTeitlebaumHRischNJekelJOstfeldA: Influence of dietary fat, apolipoprotein E phenotype, and sex on plasma lipoprotein levelsCirculation1992, 86:849–857.
57.
LehtimäkiTMoilanenMSolakiviTLaippalaPEhnholmC: Cholesterol-rich diet induced changes in plasma lipids in relation to apolipoprotein E phenotype in healthy studentsAnn Med1992, 24:61–66.
58.
XuC-FBoerwinkleETikkanenMJHuttunenJKHumphriesSETalmudPJ: Genetic variation at the apolipoprotein gene loci contribute to response of plasma lipids to dietary changeGenet Epidemiol1990, 7:261–275.
59.
TalmudPJBoerwinkleEXuCTikkanenMJPietinenPHuttunenJK: Dietary intake and gene variation influence the response of plasma lipids to dietary intervention. GenetEpidemiol1992, 9:249–260.
60.
GyllingHMiettinenTA: Cholesterol absorption and synthesis related to low density lipoprotein metabolism during varying cholesterol intake in men with different apoE phenotypesJ Lipid Res1992, 33:1361–1371.
61.
KesäniemiYAEhnholmCMiettinenTA: Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotypeJ Clin Invest1987, 80:578–581.
62.
DreonDMFernstromHAMillerBKraussRM: Apolipoprotein E isoform phenotype and LDL subclass response to a reduced-fat dietArterioscler Thromb Vasc Biol1995, 15:105–111.
63.
EichnerJEKullerLHOrchardTJGranditsGAMcCallumLMFerrellRE: Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery diseaseAm J Cardiol1993, 71:160–165.
64.
NestruckACBouthillierDSingCFDavignonJ: Apolipoprotein E polymorphism and plasma cholesterol response to probucolMetabolism1987, 36:743–747.
65.
de KnijffPStalenhoefAFHMolMJTMLeuvenJAGSmitJErkelensDW: Influence of apo E polymorphism on the response to simvastatin treatment in patients with heterozygous familial hypercholesterolemiaAtherosclerosis1990, 83:89–97.
66.
O'MalleyJPIllingworthDR: The influence of apolipoprotein E phenotype on the response to lovastatin therapy in patients with heterozygous familial hypercholesterolemiaMetabolism1990, 39:150–154.
67.
OjalaJ-PHelveEEhnholmCAalto-SetäläKKontulaKKTikkanenMJ: Effect of apolipoprotein E polymorphism and Xbal polymorphism of apolipoprotein B on response to lovastatin treatment in familial and non-familial hypercholesterolaemiaJ Intern Med1991, 230:397–405.
68.
CarmenaRRoedererGMaillouxHLussier-CacanSDavignonJ: The response to lovastatin treatment in patients with heterozygous familial hypercholesterolemia is modulated by apolipoprotein E polymorphismMetabolism1993, 42:895–901.
69.
StrittmatterWJSaundersAMSchmechelDPericak-VanceMEnghildJSalvesenGS: Apolipoprotein E: High avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer diseaseProc Natl Acad Sci USA1993, 90:1977–1981.